Rating Rationale
November 15, 2022 | Mumbai
R.S. Enterprises (Bangalore) Private Limited
'CRISIL BB+ / Stable' assigned to Bank Debt
 
Rating Action
Total Bank Loan Facilities RatedRs.11 Crore
Long Term RatingCRISIL BB+/Stable (Assigned)
Note: None of the Directors on CRISIL Ratings Limited’s Board are members of rating committee and thus do not participate in discussion or assignment of any ratings. The Board of Directors also does not discuss any ratings at its meetings.
1 crore = 10 million
Refer to Annexure for Details of Instruments & Bank Facilities

Detailed Rationale

CRISIL Ratings has assigned its 'CRISIL BB+/Stable' rating to the long-term bank facilities of R.S. Enterprises (Bangalore) Private Limited (RSEPL).

 

The rating reflects RSEPL's established market presence and extensive experience of the promoters in the distribution of pharmaceutical products and healthcare equipment and its healthy financial profile. These strengths are partially offset by its exposure to intense competition, geographical concentration risk in revenue profile and working capital intensive operations.

Key Rating Drivers & Detailed Description

Strengths:

Established market presence and extensive industry experience of the promoters: The promoters of RSEPL are in this line of business for more than 3 decades and has good understanding of the industry dynamics, especially in Karnataka. Mr. Prakash Revankar was instrumental in securing exclusive agreements with the manufactures of surgical gloves, Kurian Abrahan Private Limited (KAPL) and Stryker India for distribution across the districts of Karnataka. Over the time, the promoters' have developed good relationships with several suppliers and customers.

 

Healthy financial profile: RSEPL’s capital structure have been at healthy level due to lower reliance on external funds yielding gearing of 0.2 time and low total outside liabilities to adjusted tangible networth (TOL/ANW) of 0.4 time for year ending on 31st March 2022. RSEPL’s debt protection measures have also been at healthy levels due to its comfortable leverage position and healthy profitability.  The interest coverage and net cash accrual to total debt (NCATD) ratio are at 6.34 times and 0.54 time for fiscal 2022. RSEPL’s debt protection measures are expected to remain at similar level over medium term.

 

Weaknesses

Exposure to intense competition: Due to presence of large number of organized and unorganized players in the segment driven by low capital requirement, the industry is exposed to intense competition. Therefore, scale of operations determines the negotiating power with suppliers and customers, and ability to withstand business downturns.

 

Geographical concentration risk in revenue profile: RSEPL has high geographic concentration in its revenue profile.  About 95 percent of revenues is generated from Karnataka region. Any disruptions in supply chain, customer relationships could lead to impact on its revenues. With continuation of similar strategy by the company, CRISIL Ratings expects the revenues to have high geographic concentration over the medium term.

 

Working capital intensive operations: RSEPL’s intense working capital requirement is reflected in its gross current assets (GCA) of 186 days as on March 31, 2022. It's large working capital requirements arise from its high debtor and inventory levels. Usually, a longer credit period is extended to government as well as top private hospitals, with which RSEPL has a long-term business association. Furthermore, due to its business need, it stocks about 2-3 months of inventory in its warehouses.

Liquidity Adequate

Bank limit utilisation is low at around 23 percent for the past twelve months ended September 2022.  Annual net cash accruals are expected to be over Rs 4 crore against which company has no term debt obligation, over the medium term. Hence, it will be act as cushion to the liquidity of the company. Current ratio is healthy at 3.68 times on March 31, 2022. The promoters are likely to extend support in the form of equity and unsecured loans to meet its working capital requirements and repayment obligations.

Outlook Stable

CRISIL Ratings believes RSEPL will continue to benefit over the medium term from its longstanding relationships with principals and experience of the management to mitigate the inherent risk in trading business. 

Rating Sensitivity factors

Upward factors

  • Sustained improvement in revenue and margins leading to cash accruals above Rs. 8 crore over the medium term, while sustaining its comfortable financial risk profile.
  • Improvement in working capital cycle, with gross current assets improve to below 150 days, helped by improved debtor realization, on a sustained basis

 

Downward factors

  • Significant decline in revenue and/or margins resulting in cash accruals below Rs. 3 crore on a consistent basis
  • Further stretch in working capital cycle due to delayed debtor realisation and/or inventory pile-up

About the Company

Bangalore based, RSEPL was incorporated in July 1998. It is engaged in the business of distribution of pharmaceuticals, surgical gloves, implants and equipment. The company is an authorized wholesale dealer for medical equipment manufacturers such as Stryker India and Kurian Abrahan Private Limited (KAPL; 'SERJUN' brand surgical gloves) across Karnataka region. It has warehouses and marketing offices located at Bangalore, Mangalore, Mysore and Belgaum. The company caters to over 500 clients which include corporate hospitals, nursing homes, chemists & druggists, doctors.

 

RSEPL is owned & managed by Mr. Prakash Revankar and Mrs.  Saroj P. Revankar.     

Key Financial Indicators

As on / for the period ended March 31

 

2022

2021

Operating income

Rs crore

102.16

79.80

Reported profit after tax

Rs crore

3.69

2.10

PAT margins

%

3.60

2.62

Adjusted Debt/Adjusted Net worth

Times

0.18

0.34

Interest coverage

Times

6.22

3.98

Any other information: Not applicable

Note on complexity levels of the rated instrument:
CRISIL Ratings` complexity levels are assigned to various types of financial instruments and are included (where applicable) in the ‘Annexure – Details of Instrument’ in this Rating Rationale.

CRISIL Ratings will disclose complexity level for all securities – including those that are yet to be placed - based on available information. The complexity level for instruments may be updated, where required, in the rating rationale published subsequent to the issuance of the instrument when details on such features are available.

For more details on the CRISIL Ratings` complexity levels please visit www.crisil.com/complexity-levels. Users may also call the Customer Service Helpdesk with queries on specific instruments.

Annexure - Details of Instrument(s)

ISIN Name of instrument Date of Allotment Coupon Rate (%) Maturity Date Issue Size (Rs Cr) Complexity Levels Rating Assigned with Outlook
NA` Cash Credit   NA  NA NA 11 NA CRISIL BB+/Stable
Annexure - Rating History for last 3 Years
  Current 2022 (History) 2021  2020  2019  Start of 2019
Instrument Type Outstanding Amount Rating Date Rating Date Rating Date Rating Date Rating Rating
Fund Based Facilities LT 11.0 CRISIL BB+/Stable   --   -- 23-10-20 Withdrawn (Issuer Not Cooperating)* 25-07-19 CRISIL BB+ /Stable(Issuer Not Cooperating)* CRISIL BB+/Stable
      --   --   -- 20-10-20 CRISIL B /Stable(Issuer Not Cooperating)*   -- --
All amounts are in Rs.Cr.
* - Issuer did not cooperate; based on best-available information
 
Annexure - Details of Bank Lenders & Facilities
Facility Amount (Rs.Crore) Name of Lender Rating
Cash Credit 11 Canara Bank CRISIL BB+/Stable

This Annexure has been updated on 15-Nov-2022 in line with the lender-wise facility details as on 14-Nov-2022 received from the rated entity.

Criteria Details
Links to related criteria
CRISILs Approach to Financial Ratios
CRISILs Bank Loan Ratings - process, scale and default recognition
Criteria for rating trading companies
Assessing Information Adequacy Risk
Rating Criteria for the Pharmaceutical Industry

Media Relations
Analytical Contacts
Customer Service Helpdesk

Aveek Datta
Media Relations
CRISIL Limited
M: +91 99204 93912
B: +91 22 3342 3000
AVEEK.DATTA@crisil.com

Prakruti Jani
Media Relations
CRISIL Limited
M: +91 98678 68976
B: +91 22 3342 3000
PRAKRUTI.JANI@crisil.com

Rutuja Gaikwad 
Media Relations
CRISIL Limited
B: +91 22 3342 3000
Rutuja.Gaikwad@ext-crisil.com


Himank Sharma
Director
CRISIL Ratings Limited
D:+91 124 672 2152
himank.sharma@crisil.com


Jayashree Nandakumar
Associate Director
CRISIL Ratings Limited
D:+91 40 4032 8218
jayashree.nandakumar@crisil.com


Naveen Surendran
Manager
CRISIL Ratings Limited
B:+91 22 4040 5800
Naveen.Surendran@crisil.com
Timings: 10.00 am to 7.00 pm
Toll free Number:1800 267 1301

For a copy of Rationales / Rating Reports:
CRISILratingdesk@crisil.com
 
For Analytical queries:
ratingsinvestordesk@crisil.com


 

Note for Media:
This rating rationale is transmitted to you for the sole purpose of dissemination through your newspaper/magazine/agency. The rating rationale may be used by you in full or in part without changing the meaning or context thereof but with due credit to CRISIL Ratings. However, CRISIL Ratings alone has the sole right of distribution (whether directly or indirectly) of its rationales for consideration or otherwise through any media including websites and portals.


About CRISIL Ratings Limited (A subsidiary of CRISIL Limited)

CRISIL Ratings pioneered the concept of credit rating in India in 1987. With a tradition of independence, analytical rigour and innovation, we set the standards in the credit rating business. We rate the entire range of debt instruments, such as bank loans, certificates of deposit, commercial paper, non-convertible/convertible/partially convertible bonds and debentures, perpetual bonds, bank hybrid capital instruments, asset-backed and mortgage-backed securities, partial guarantees and other structured debt instruments. We have rated over 33,000 large and mid-scale corporates and financial institutions. We have also instituted several innovations in India in the rating business, including ratings for municipal bonds, partially guaranteed instruments and infrastructure investment trusts (InvITs).
 
CRISIL Ratings Limited ('CRISIL Ratings') is a wholly-owned subsidiary of CRISIL Limited ('CRISIL'). CRISIL Ratings Limited is registered in India as a credit rating agency with the Securities and Exchange Board of India ("SEBI").
 
For more information, visit www.crisilratings.com 

 



About CRISIL Limited

CRISIL is a global analytical company providing ratings, research, and risk and policy advisory services. We are India's leading ratings agency. We are also the foremost provider of high-end research to the world's largest banks and leading corporations.

CRISIL is majority owned by S&P Global Inc, a leading provider of transparent and independent ratings, benchmarks, analytics and data to the capital and commodity markets worldwide.


For more information, visit www.crisil.com

Connect with us: TWITTER | LINKEDIN | YOUTUBE | FACEBOOK


CRISIL PRIVACY NOTICE
 
CRISIL respects your privacy. We may use your contact information, such as your name, address and email id to fulfil your request and service your account and to provide you with additional information from CRISIL. For further information on CRISIL’s privacy policy please visit www.crisil.com.



DISCLAIMER

This disclaimer is part of and applies to each credit rating report and/or credit rating rationale (‘report’) that is provided by CRISIL Ratings Limited (‘CRISIL Ratings’). To avoid doubt, the term ‘report’ includes the information, ratings and other content forming part of the report. The report is intended for the jurisdiction of India only. This report does not constitute an offer of services. Without limiting the generality of the foregoing, nothing in the report is to be construed as CRISIL Ratings providing or intending to provide any services in jurisdictions where CRISIL Ratings does not have the necessary licenses and/or registration to carry out its business activities referred to above. Access or use of this report does not create a client relationship between CRISIL Ratings and the user.

We are not aware that any user intends to rely on the report or of the manner in which a user intends to use the report. In preparing our report we have not taken into consideration the objectives or particular needs of any particular user. It is made abundantly clear that the report is not intended to and does not constitute an investment advice. The report is not an offer to sell or an offer to purchase or subscribe for any investment in any securities, instruments, facilities or solicitation of any kind to enter into any deal or transaction with the entity to which the report pertains. The report should not be the sole or primary basis for any investment decision within the meaning of any law or regulation (including the laws and regulations applicable in the US).

Ratings from CRISIL Ratings are statements of opinion as of the date they are expressed and not statements of fact or recommendations to purchase, hold or sell any securities/instruments or to make any investment decisions. Any opinions expressed here are in good faith, are subject to change without notice, and are only current as of the stated date of their issue. CRISIL Ratings assumes no obligation to update its opinions following publication in any form or format although CRISIL Ratings may disseminate its opinions and analysis. The rating contained in the report is not a substitute for the skill, judgment and experience of the user, its management, employees, advisors and/or clients when making investment or other business decisions. The recipients of the report should rely on their own judgment and take their own professional advice before acting on the report in any way. CRISIL Ratings or its associates may have other commercial transactions with the entity to which the report pertains.

Neither CRISIL Ratings nor its affiliates, third-party providers, as well as their directors, officers, shareholders, employees or agents (collectively, ‘CRISIL Ratings Parties’) guarantee the accuracy, completeness or adequacy of the report, and no CRISIL Ratings Party shall have any liability for any errors, omissions or interruptions therein, regardless of the cause, or for the results obtained from the use of any part of the report. EACH CRISIL RATINGS PARTY DISCLAIMS ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING BUT NOT LIMITED TO ANY WARRANTIES OF MERCHANTABILITY, SUITABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE. In no event shall any CRISIL Ratings Party be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees or losses (including, without limitation, lost income or lost profits and opportunity costs) in connection with any use of any part of the report even if advised of the possibility of such damages.

CRISIL Ratings may receive compensation for its ratings and certain credit-related analyses, normally from issuers or underwriters of the instruments, facilities, securities or from obligors. Public ratings and analysis by CRISIL Ratings, as are required to be disclosed under the regulations of the Securities and Exchange Board of India (and other applicable regulations, if any), are made available on its website, www.crisilratings.com (free of charge). Reports with more detail and additional information may be available for subscription at a fee – more details about ratings by CRISIL Ratings are available here: www.crisilratings.com.

CRISIL Ratings and its affiliates do not act as a fiduciary. While CRISIL Ratings has obtained information from sources it believes to be reliable, CRISIL Ratings does not perform an audit and undertakes no duty of due diligence or independent verification of any information it receives and/or relies on in its reports. CRISIL Ratings has established policies and procedures to maintain the confidentiality of certain non-public information received in connection with each analytical process. CRISIL Ratings has in place a ratings code of conduct and policies for managing conflict of interest. For details please refer to:
https://www.crisil.com/en/home/our-businesses/ratings/regulatory-disclosures/highlighted-policies.html.

Rating criteria by CRISIL Ratings are generally available without charge to the public on the CRISIL Ratings public website, www.crisilratings.com. For latest rating information on any instrument of any company rated by CRISIL Ratings, you may contact the CRISIL Ratings desk at crisilratingdesk@crisil.com, or at (0091) 1800 267 1301.

This report should not be reproduced or redistributed to any other person or in any form without prior written consent from CRISIL Ratings.

All rights reserved @ CRISIL Ratings Limited. CRISIL Ratings is a wholly owned subsidiary of CRISIL Limited.

 

 

CRISIL Ratings uses the prefix ‘PP-MLD’ for the ratings of principal-protected market-linked debentures (PPMLD) with effect from November 1, 2011, to comply with the SEBI circular, "Guidelines for Issue and Listing of Structured Products/Market Linked Debentures". The revision in rating symbols for PPMLDs should not be construed as a change in the rating of the subject instrument. For details on CRISIL Ratings' use of 'PP-MLD' please refer to the notes to Rating scale for Debt Instruments and Structured Finance Instruments at the following link: https://www.crisil.com/en/home/our-businesses/ratings/credit-ratings-scale.html